<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35714658</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.</ArticleTitle><Pagination><StartPage>715</StartPage><EndPage>724</EndPage><MedlinePgn>715-724</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(22)00169-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(22)00169-2</ELocationID><Abstract><AbstractText>Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a growing global health challenge. Research on post-COVID-19 condition is expanding but, at present, no agreement exists on the health outcomes that should be measured in people living with the condition. To address this gap, we conducted an international consensus study, which included a comprehensive literature review and classification of outcomes for post-COVID-19 condition that informed a two-round online modified Delphi process followed by an online consensus meeting to finalise the core outcome set (COS). 1535 participants from 71 countries were involved, with 1148 individuals participating in both Delphi rounds. Eleven outcomes achieved consensus for inclusion in the final COS: fatigue; pain; post-exertion symptoms; work or occupational and study changes; survival; and functioning, symptoms, and conditions for each of cardiovascular, respiratory, nervous system, cognitive, mental health, and physical outcomes. Recovery was included a priori because it was a relevant outcome that was part of a previously published COS on COVID-19. The next step in this COS development exercise will be to establish the instruments that are most appropriate to measure these core outcomes. This international consensus-based COS should provide a framework for standardised assessment of adults with post-COVID-19 condition, aimed at facilitating clinical care and research worldwide.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 World Health Organization. Published by Elsevier Ltd. All rights reserved. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munblit</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK; Research and Clinical Center for Neuropsychiatry, Moscow, Russia. Electronic address: daniel.munblit08@imperial.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akrami</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, UCL, London, UK; Patient-Led Research Collaborative, Otto von Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfelbacher</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Groote</LastName><ForeName>Wouter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Noncommunicable Diseases, Rehabilitation Programme, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Janet V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Clinical Management Team, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorst</LastName><ForeName>Sarah L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Health Data Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harman</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MRC/NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokorina</LastName><ForeName>Alisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pirogov Russian National Research Medical University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olliaro</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>ISARIC Global Support Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parr</LastName><ForeName>Callum</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preller</LastName><ForeName>Jacobus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Care Readiness Unit, Health Emergencies Unit, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiess</LastName><ForeName>Nicoline</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brain Health Unit, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Evidence-based Healthcare, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seylanova</LastName><ForeName>Nina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Coventry University, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sydney School of Public Health, The University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Needham</LastName><ForeName>Dale M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Outcomes After Critical Illness and Surgery Research Group, Pulmonary and Critical Care Medicine, Department of Medicine, and Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Paula R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>MRC/NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PC-COS project steering committee</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>MC_PC_19026</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20050</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2022 Jul;10(7):628-629. doi: 10.1016/S2213-2600(22)00211-9</RefSource><PMID Version="1">35714657</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2022 Jul;10(7):630-631. doi: 10.1016/S2213-2600(22)00219-3</RefSource><PMID Version="1">35716674</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003697" MajorTopicYN="N">Delphi Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests DM is a co-chair of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Global Paediatric Long COVID working group and a member of the ISARIC working group on long-term follow-up in adults. CA reports grants or contracts from Dr Wolff Group, Bionorica, and The European Cooperation in Science and Technology; consulting fees from the Dr Wolff Group, Bionorica, and Sanofi-Aventis Germany; and honoraria from AstraZeneca. SLG is the project coordinator of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. PRW is chair of the COMET Management Group. All other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Guekht</LastName><ForeName>Alla</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm Calum G</ForeName><Initials>MCG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warner</LastName><ForeName>John O</ForeName><Initials>JO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sigfrid</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>Janet T</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>DunnGalvin</LastName><ForeName>Audrey</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Genuneit</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Siegerink</LastName><ForeName>Bob</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klok</LastName><ForeName>Frederikus A</ForeName><Initials>FA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Avdeev</LastName><ForeName>Sergey</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stavropoulou</LastName><ForeName>Charitini</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Michelen</LastName><ForeName>Melina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aiyegbusi</LastName><ForeName>Olalekan Lee</ForeName><Initials>OL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calvert</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hughes</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haroon</LastName><ForeName>Shamil</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fregonese</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carson</LastName><ForeName>Gail</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knauss</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herridge</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murthy</LastName><ForeName>Srinivas</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vos</LastName><ForeName>Theo</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wulf Hanson</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Ann</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Kelly K</ForeName><Initials>KK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lerner</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chevinsky</LastName><ForeName>Jennifer R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Unger</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eisinger</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hough</LastName><ForeName>Catherine L</ForeName><Initials>CL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saydah</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frontera</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosa</LastName><ForeName>Regis Goulart</ForeName><Initials>RG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cao</LastName><ForeName>Bin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatnagar</LastName><ForeName>Shinjini</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiruvengadam</LastName><ForeName>Ramachandran</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seahwag</LastName><ForeName>Archana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bouraoui</LastName><ForeName>Anouar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Kerkhove</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dua</LastName><ForeName>Tarun</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Relan</LastName><ForeName>Pryanka</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soriano Ortiz</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>17</Day><Hour>19</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35714658</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pii">S2213-2600(22)00169-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang L, Yao Q, Gu X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyar J, Adams CE. Content and quality of 10,000 controlled trials in schizophrenia over 60 years. Schizophr Bull. 2013;39:226&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3523927</ArticleId><ArticleId IdType="pubmed">22290267</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargon E, Gorst SL, Matvienko-Sikar K, Williamson PR. Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for research. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802923</ArticleId><ArticleId IdType="pubmed">33434219</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson PR, Altman DG, Bagley H, et al. The COMET handbook: version 1.0. Trials. 2017;18(suppl 3):280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5499094</ArticleId><ArticleId IdType="pubmed">28681707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkham JJ, Davis K, Altman DG, et al. Core Outcome Set&#x2013;STAndards for Development: the COS-STAD recommendations. PLoS Med. 2017;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689835</ArticleId><ArticleId IdType="pubmed">29145404</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinsen CA, Vohra S, Rose MR, et al. How to select outcome measurement instruments for outcomes included in a &#x201c;Core Outcome Set&#x201d; &#x2013; a practical guideline. Trials. 2016;17:449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020549</ArticleId><ArticleId IdType="pubmed">27618914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan J, Heiberg T, Hewlett S, et al. Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol. 2003;30:868&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pubmed">12672218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkham JJ, Clarke M, Williamson PR. A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis. BMJ. 2017;357</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434459</ArticleId><ArticleId IdType="pubmed">28515234</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Williamson P, et al.  Core outcome measures for post-Covid condition/long Covid. https://www.comet-initiative.org/Studies/Details/1847</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd S, Clarke M, Becker L, Mavergames C, Fish R, Williamson PR. A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. J Clin Epidemiol. 2018;96:84&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854263</ArticleId><ArticleId IdType="pubmed">29288712</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong A, Baumgart A, Evangelidis N, et al. Core outcome measures for trials in people with coronavirus disease 2019: respiratory failure, multiorgan failure, shortness of breath, and recovery. Crit Care Med. 2021;49:503&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892260</ArticleId><ArticleId IdType="pubmed">33400475</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference><Reference><Citation>COMET  DelphiManager. http://www.comet-initiative.org/delphimanager</Citation></Reference><Reference><Citation>National Institute for Health Research  &#xa3;19.6 million awarded to new research studies to help diagnose and treat long COVID. July 18, 2021. https://www.nihr.ac.uk/news/196-million-awarded-to-new-research-studies-to-help-diagnose-and-treat-long-covid/28205</Citation></Reference><Reference><Citation>National Institutes of Health  NIH launches new initiative to study &#x201c;long COVID&#x201d;. Feb 23, 2021. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid</Citation></Reference><Reference><Citation>Tong A, Elliott JH, Azevedo LC, et al. Core outcomes set for trials in people with coronavirus disease 2019. Crit Care Med. 2020;48:1622&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448717</ArticleId><ArticleId IdType="pubmed">32804792</ArticleId></ArticleIdList></Reference><Reference><Citation>Core Outcome Measures in Effectiveness Trials (COMET) Initiative  Core outcome set developers' response to COVID-19. April 2021. https://www.comet-initiative.org/studies/details/1538</Citation></Reference><Reference><Citation>Needham DM, Sepulveda KA, Dinglas VD, et al. Core outcome measures for clinical research in acute respiratory failure survivors. An international modified Delphi consensus study. Am J Respir Crit Care Med. 2017;196:1122&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5694837</ArticleId><ArticleId IdType="pubmed">28537429</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O'Brien KK. Conceptualising long COVID as an episodic health condition. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Sigfrid L, Warner JO. Setting priorities to address research gaps in long-term COVID-19 outcomes in children. JAMA Pediatr. 2021;175:1095&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">34338711</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Buonsenso D, Sigfrid L, Vijverberg SJH, Brackel CLH. Post-COVID-19 condition in children: a COS is urgently needed. Lancet Respir Med. 2022 doi: 10.1016/S2213-2600(22)00211-9. published online June 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00211-9</ArticleId><ArticleId IdType="pmc">PMC9197248</ArticleId><ArticleId IdType="pubmed">35714657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes KL, Clarke M, Williamson PR. A systematic review finds core outcome set uptake varies widely across different areas of health. J Clin Epidemiol. 2021;129:114&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7815247</ArticleId><ArticleId IdType="pubmed">32987162</ArticleId></ArticleIdList></Reference><Reference><Citation>Akinremi A, Turnbull AE, Chessare CM, Bingham CO, 3rd, Needham DM, Dinglas VD. Delphi panelists for a core outcome set project suggested both new and existing dissemination strategies that were feasibly implemented by a research infrastructure project. J Clin Epidemiol. 2019;114:104&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">31173895</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Simpson F, Mabbitt J, Dunn-Galvin A, Semple C, Warner JO. Legacy of COVID-19 infection in children: long-COVID will have a lifelong health/economic impact. Arch Dis Child. 2022;107:e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">34045207</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson TR, Needham DM, et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of core outcome set development. BMC Med. 2022;20:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature Medicine Meeting the challenge of long COVID. Nat Med. 2020;26</Citation><ArticleIdList><ArticleId IdType="pubmed">33288947</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>